New-generation Analytical Platform Accelerates Analysis of Trace Elements for Routine Laboratory Applications

SAN JOSE, Calif., March 31, 2020 /PRNewswire/ — Scientists no longer need to limit routine trace element analysis workflow productivity with the launch of a new series of inductively coupled plasma optical emission spectroscopy (ICP-OES) instruments for food and beverage, consumer safety, industrial, environmental and pharmaceutical laboratories.

The Thermo Scientific iCAP PRO Series ICP-OES platform is designed to provide a fast, sensitive range of trace element analysis solutions capable of capturing the complete spectrum of high matrix samples in a single run, improving workflow productivity and reducing analysis costs. From standby to start-up in just five minutes, the new instruments reduce gas consumption within a vertical dual-purged optical pathway interface that has lower installation requirements due to its standard wall socket and low extraction flow rate. 

“The analysis of trace elements in high matrix samples is essential for laboratory teams across a number of sectors to assure the quality, consistency and safety of products and the environment we live in, but it traditionally presents acute analytical and resource challenges that limit routine deployment,” said Adrian Holley, director, product marketing, trace element analysis, chromatography and mass spectrometry, Thermo Fisher Scientific. “The launch of the iCAP PRO Series ICP-OES platform helps laboratories bypass traditional sample preparation requirements and the need to undertake multiple measurements, providing a range of trace element analysis solutions that enhance workflow productivity and reduce cost-per-sample.”

Mike Dudley, laboratory supervisor, fluid analysis laboratory, Carter Machinery Company, a producer of lubricants for engines and other mechanical purposes, said, “We have been running the iCAP PRO Series ICP-OES platform for several weeks and are very pleased. We have reduced our run time by 36%. Our numbers are looking great, and my team is delighted with its performance.”

Laboratories using the iCAP PRO Series ICP-OES instruments will also benefit by:

  • Reducing the number of measurements per run to obtain a complete spectrum through the combination of a single optical slit and a charge injection device detector, delivering increased analysis speeds and readout in a reduced time frame.
  • Maximizing instrument uptime with fast start-up, making analysis possible after just five minutes.
  • Minimal recalibration of the instrument as a result of highly stable optics and polychromator.

For more information of the iCAP PRO Series ICP-OES platform, please visit www.thermofisher.com/ICP-OES.

About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $25 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, we are here to support them. Our global team of more than 75,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon. For more information, please visit www.thermofisher.com

Media Contact Information:

Laura Bright 
Thermo Fisher Scientific
+1 562-335-8318          
laura.bright@thermofisher.com

Janice Foley
BioStrata
+1 617-823-5555
jfoley@biostratamarketing.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/new-generation-analytical-platform-accelerates-analysis-of-trace-elements-for-routine-laboratory-applications-301032163.html

SOURCE Thermo Fisher Scientific

Staff

Recent Posts

Safe Supply Announces Upsize to Non-Brokered Private Placement

Toronto, Ontario--(Newsfile Corp. - December 9, 2025) - Safe Supply Streaming Co Ltd. (CSE: SPLY)…

24 minutes ago

Custom Health Announces First Closing of Brokered Private Placement of Subscription Receipts for Gross Proceeds of US$9.6M

Kelowna, British Columbia--(Newsfile Corp. - December 9, 2025) - Custom Health Inc. ("Custom Health" or…

1 hour ago

Rural Care Reimagined: Avel eCare Multipoint EMS Model Supports Stronger Hospitals and Communities

SIOUX FALLS, SD / ACCESS Newswire / December 9, 2025 / When a medical emergency…

2 hours ago

Results from Phase 1 Multiple-Dose Study of PT00114

Findings support advancement into Phase 2 to explore a first-in-class pathway aimed at stress-related neuropsychiatric…

2 hours ago

Aptevo Therapeutics Highlights Compelling Safety and Strong Remission Rates for Mipletamig in Frontline AML at ASH 2025

100% of patients in Cohorts 1-3 remain free of cytokine release syndromeCRIS-7-derived CD3 design underpins…

2 hours ago